Friday, June 02, 2006

GSK $15 billion bid for Pfizer's OTC biz

GSK is to bid more than $15 billion for the consumer healthcare business of Pfizer, its U.S rival, according to people close to the negotiations, the Financial Times said on Friday.

Well done guys.

Dont miss out on this one, like you did with Boots!

No comments: